Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

A John Rush

Biographic Data

ID2121959
NAMEA John Rush
GIVEN NAMESA John
FAMILY NAMERush
SIGNATURERUSH A J
AFFILIATIONSThe University of Texas Southwestern Medical Center
ORCID0000-0003-2004-2382
VERIFIEDYes
TOTAL WORKS23
TOTAL CITATIONS18
AUTHOR COUNT22
EDITOR COUNT1
FIRST PUBLICATION YEAR1965
LATEST PUBLICATION YEAR2026
H-INDEX2
  • Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints

    Open Access•Sharon C Sung, Sharon Sung et al.•ARTICLE•Frontiers in Psychiatry•2026

    This newly derived model demonstrated strong diagnostic accuracy in identifying panic-related anxiety among ED patients with cardiopulmonary complaints, suggesting its potential utility in clinical screening. Implementation of this model may facilitate timely diagnosis, reduce repeated ED visits, and improve patient outcomes

  • The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk: Performance in adult primary care patients

    Open Access•Karabi Nandy, A John Rush et al.•ARTICLE•Frontiers in Psychiatry•2023

    The CHRT-SR 9 is a brief self-report evaluating suicidality with excellent psychometric properties that is sensitive to change over time

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

    Open Access•Guy M Goodwin, Scott T Aaronson et al.•ARTICLE•New England Journal of Medicine•2022

    BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…

  • Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials

    Zachary Herrmann, M Earleywine et al.•ARTICLE•Journal of Psychoactive Drugs•2022

    Subjective responses to psychoactive drugs have served as intriguing windows into consciousness as well as useful predictors. Subjective reactions to psychedelic molecules are particularly interesting given how they covary with subsequent improvements associated with psychedelic-assisted treatments. Although links between subjective reactions and decreases in treatment-resistant clinical depression, end-of-life anxiety, and maladaptive consumptio…

  • Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population

    Open Access•John E Anderson, Jacqueline R Anderson et al.•ARTICLE•Child Psychiatry & Human…•2021

  • Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population

    Open Access•Yan Sun, Gang Chen et al.•ARTICLE•Frontiers in Psychiatry•2019

    Stigma of major depressive disorder (MDD) is an important public health problem. This study aimed to examine the level of perceived stigma and its associated factors in MDD patients in five Asian countries, including China, Korea, Malaysia, Singapore, and Thailand. A total of 547 outpatients with MDD were included from Asian countries. We used the stigma scale of the Explanatory Model Interview Catalogue (EMIC) to assess stigma. The Montgomery-As…

  • Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication

    Marisa S P Toups, Marisa Toups et al.•ARTICLE•Psychosomatic Medicine•2013

    OBJECTIVE: Obesity and major depressive disorder often co-occur. However, differences between obese and normal-weight depressed patients and the moderating effect of obesity on antidepressant treatment outcome are not well studied. METHODS: Adults (n = 662) with major depressive disorder in the Combining Medications to Enhance Depression Outcomes study were randomized to treatment with escitalopram plus placebo, bupropion plus escitalopram, or ve…

  • Health Impacts of Caregiving for Older Adults With Functional Limitations: Results From the Singapore Survey on Informal Caregiving

    Open Access•Angelique Chan, CHETNA MALHOTRA et al.•ARTICLE•Journal of Aging and Health•2013•Cited by: 1•References: 6

    The study indicates the need for support services to family caregivers of older adults with ADL limitations

  • Measuring Use and Cost of Care for Patients With Mood Disorders: The Utilization and Cost Inventory

    T MICHAEL KASHNER, Michael D Stensland et al.•ARTICLE•Medical Care•2009•References: 36

    BACKGROUND: Researchers conducting cost-outcome studies must account for all materially relevant care that subjects receive from their care providers. However, access to provider records is often limited. This article describes and tests the Utilization and Cost Inventory (UAC-I), a structured patient interview designed to measure costs of care when access to provider records is limited. METHODS: UAC-I was tested on 212 consenting adult veterans …

  • Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment

    Open Access•Cynthia Ewell Foster, Melissa C Webster et al.•ARTICLE•Journal of Youth and Adolescence•2008•Cited by: 9•References: 36

  • Ethnicity/Race and Outcome in the Treatment of Depression: Results From STAR*D

    Ira M Lesser, Daniel Castro et al.•ARTICLE•Medical Care•2007•References: 44

    OBJECTIVES: This secondary analysis of data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study compared rates of remission and response for blacks (n = 495), whites (n = 1853), and Hispanics (n = 327) with nonpsychotic major depressive disorder who were treated with citalopram. METHODS: STAR*D included representative outpatients treated in 23 psychiatric and 18 primary care centers. Participants received flexible doses…

  • Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

    Madhukar H Trivedi, A John Rush et al.•ARTICLE•American Journal of Psychiatry•2006

    OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established. The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.…

  • Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

    A John Rush, Madhukar H Trivedi et al.•ARTICLE•American Journal of Psychiatry•2006

    OBJECTIVE: This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. METHOD: A broadly representative adult outpatient sample with nonpsychotic major depressive disorder received one (N=3,671) to four (N=123) successive acute treatment steps. Those not achieving remission with or unable…

  • The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)

    R C Kessler, Patricia Berglund et al.•ARTICLE•JAMA•2003

    CONTEXT: Uncertainties exist about prevalence and correlates of major depressive disorder (MDD). OBJECTIVE: To present nationally representative data on prevalence and correlates of MDD by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, and on study patterns and correlates of treatment and treatment adequacy from the recently completed National Comorbidity Survey Replication (NCS-R). DESIGN: Face-to-face h…

  • The 16-Item quick inventory of depressive symptomatology (Qids), clinician rating (Qids-C), and self-report (Qids-SR): A psychometric evaluation in patients with chronic major depression

    Open Access•A John Rush, Madhukar H Trivedi et al.•ARTICLE•Biological Psychiatry•2003

  • Dream recall and major depression: A preliminary report

    Roseanne Armitage, Aaron B Rochlen et al.•ARTICLE•Dreaming•1995•Cited by: 8•References: 3

  • Clinical practice guidelines for managing major depression in primary care practice: Implications for psychologists

    Herbert C Schulberg, A John Rush•ARTICLE•American Psychologist•1994

    Clinical practice guidelines are being developed by professional and governmental bodies to improve the quality of health care. The guidelines developed by the U.S. Public Health Service Agency for Health Care Policy and Research seek to improve the primary care physician's ability to diagnose and treat major depression. Clinical, educational, and research implications for psychologists are considered in light of how the recommended guidelines po…

  • Mind, Mood, and Medicine: A Guide to the New Biopsychiatry

    A John Rush, John A Rush•ARTICLE•Psychosomatic Medicine•1984

  • Psychotherapie-Manual: Sammlung Psychotherapeutischer Techniken und Einzelverfahren

    Open Access•S von Aster, T Ayllon et al.•BOOK•Psychotherapie-Manual•1981

  • Psychotherapy of the affective psychoses

    Open Access•A John Rush•ARTICLE•The American Journal of…•1980

  • The Problem Oe Drug Abuse: Research and Policy Needs: A View From the Public Sector

    Meyer Balter, A John Rush•ARTICLE•Public Opinion Quarterly•1972

    Journal Article THE PROBLEM OE DRUG ABUSE: RESEARCH AND POLICY NEEDS: A VIEW FROM THE PUBLIC SECTOR Get access Mitchell Balter, Mitchell Balter Chairman Special Action Office for Drug Abuse Prevention Search for other works by this author on: Oxford Academic Google Scholar A. John Rush A. John Rush Special Action Office for Drug Abuse Prevention Search for other works by this author on: Oxford Academic Google Scholar Public Opinion Quarterly, Vol…

  • Catholic Hymns

    Francis Cameron, A John Rush et al.•ARTICLE•The Musical Times•1968

  • A Beginner's Plainsong

    A John Rush, John Rush et al.•ARTICLE•British Journal of Educational…•1965

  • Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment

    Open Access•Cynthia Ewell Foster, Melissa C Webster et al.•ARTICLE•Journal of Youth and Adolescence•2008•Cited by: 9•References: 36

  • Dream recall and major depression: A preliminary report

    Roseanne Armitage, Aaron B Rochlen et al.•ARTICLE•Dreaming•1995•Cited by: 8•References: 3

  • Health Impacts of Caregiving for Older Adults With Functional Limitations: Results From the Singapore Survey on Informal Caregiving

    Open Access•Angelique Chan, CHETNA MALHOTRA et al.•ARTICLE•Journal of Aging and Health•2013•Cited by: 1•References: 6

    The study indicates the need for support services to family caregivers of older adults with ADL limitations

  • A Beginner's Plainsong

    A John Rush, John Rush et al.•ARTICLE•British Journal of Educational…•1965

  • Catholic Hymns

    Francis Cameron, A John Rush et al.•ARTICLE•The Musical Times•1968

  • The Problem Oe Drug Abuse: Research and Policy Needs: A View From the Public Sector

    Meyer Balter, A John Rush•ARTICLE•Public Opinion Quarterly•1972

    Journal Article THE PROBLEM OE DRUG ABUSE: RESEARCH AND POLICY NEEDS: A VIEW FROM THE PUBLIC SECTOR Get access Mitchell Balter, Mitchell Balter Chairman Special Action Office for Drug Abuse Prevention Search for other works by this author on: Oxford Academic Google Scholar A. John Rush A. John Rush Special Action Office for Drug Abuse Prevention Search for other works by this author on: Oxford Academic Google Scholar Public Opinion Quarterly, Vol…

  • Psychotherapy of the affective psychoses

    Open Access•A John Rush•ARTICLE•The American Journal of…•1980

  • Psychotherapie-Manual: Sammlung Psychotherapeutischer Techniken und Einzelverfahren

    Open Access•S von Aster, T Ayllon et al.•BOOK•Psychotherapie-Manual•1981

  • Mind, Mood, and Medicine: A Guide to the New Biopsychiatry

    A John Rush, John A Rush•ARTICLE•Psychosomatic Medicine•1984

  • Clinical practice guidelines for managing major depression in primary care practice: Implications for psychologists

    Herbert C Schulberg, A John Rush•ARTICLE•American Psychologist•1994

    Clinical practice guidelines are being developed by professional and governmental bodies to improve the quality of health care. The guidelines developed by the U.S. Public Health Service Agency for Health Care Policy and Research seek to improve the primary care physician's ability to diagnose and treat major depression. Clinical, educational, and research implications for psychologists are considered in light of how the recommended guidelines po…

  • Dream recall and major depression: A preliminary report

    Roseanne Armitage, Aaron B Rochlen et al.•ARTICLE•Dreaming•1995•Cited by: 8•References: 3

  • The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)

    R C Kessler, Patricia Berglund et al.•ARTICLE•JAMA•2003

    CONTEXT: Uncertainties exist about prevalence and correlates of major depressive disorder (MDD). OBJECTIVE: To present nationally representative data on prevalence and correlates of MDD by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, and on study patterns and correlates of treatment and treatment adequacy from the recently completed National Comorbidity Survey Replication (NCS-R). DESIGN: Face-to-face h…

  • The 16-Item quick inventory of depressive symptomatology (Qids), clinician rating (Qids-C), and self-report (Qids-SR): A psychometric evaluation in patients with chronic major depression

    Open Access•A John Rush, Madhukar H Trivedi et al.•ARTICLE•Biological Psychiatry•2003

  • Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

    Madhukar H Trivedi, A John Rush et al.•ARTICLE•American Journal of Psychiatry•2006

    OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established. The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.…

  • Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

    A John Rush, Madhukar H Trivedi et al.•ARTICLE•American Journal of Psychiatry•2006

    OBJECTIVE: This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. METHOD: A broadly representative adult outpatient sample with nonpsychotic major depressive disorder received one (N=3,671) to four (N=123) successive acute treatment steps. Those not achieving remission with or unable…

  • Ethnicity/Race and Outcome in the Treatment of Depression: Results From STAR*D

    Ira M Lesser, Daniel Castro et al.•ARTICLE•Medical Care•2007•References: 44

    OBJECTIVES: This secondary analysis of data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study compared rates of remission and response for blacks (n = 495), whites (n = 1853), and Hispanics (n = 327) with nonpsychotic major depressive disorder who were treated with citalopram. METHODS: STAR*D included representative outpatients treated in 23 psychiatric and 18 primary care centers. Participants received flexible doses…

  • Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment

    Open Access•Cynthia Ewell Foster, Melissa C Webster et al.•ARTICLE•Journal of Youth and Adolescence•2008•Cited by: 9•References: 36

  • Measuring Use and Cost of Care for Patients With Mood Disorders: The Utilization and Cost Inventory

    T MICHAEL KASHNER, Michael D Stensland et al.•ARTICLE•Medical Care•2009•References: 36

    BACKGROUND: Researchers conducting cost-outcome studies must account for all materially relevant care that subjects receive from their care providers. However, access to provider records is often limited. This article describes and tests the Utilization and Cost Inventory (UAC-I), a structured patient interview designed to measure costs of care when access to provider records is limited. METHODS: UAC-I was tested on 212 consenting adult veterans …

  • Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication

    Marisa S P Toups, Marisa Toups et al.•ARTICLE•Psychosomatic Medicine•2013

    OBJECTIVE: Obesity and major depressive disorder often co-occur. However, differences between obese and normal-weight depressed patients and the moderating effect of obesity on antidepressant treatment outcome are not well studied. METHODS: Adults (n = 662) with major depressive disorder in the Combining Medications to Enhance Depression Outcomes study were randomized to treatment with escitalopram plus placebo, bupropion plus escitalopram, or ve…

  • Health Impacts of Caregiving for Older Adults With Functional Limitations: Results From the Singapore Survey on Informal Caregiving

    Open Access•Angelique Chan, CHETNA MALHOTRA et al.•ARTICLE•Journal of Aging and Health•2013•Cited by: 1•References: 6

    The study indicates the need for support services to family caregivers of older adults with ADL limitations

  • Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population

    Open Access•Yan Sun, Gang Chen et al.•ARTICLE•Frontiers in Psychiatry•2019

    Stigma of major depressive disorder (MDD) is an important public health problem. This study aimed to examine the level of perceived stigma and its associated factors in MDD patients in five Asian countries, including China, Korea, Malaysia, Singapore, and Thailand. A total of 547 outpatients with MDD were included from Asian countries. We used the stigma scale of the Explanatory Model Interview Catalogue (EMIC) to assess stigma. The Montgomery-As…

  • Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population

    Open Access•John E Anderson, Jacqueline R Anderson et al.•ARTICLE•Child Psychiatry & Human…•2021

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

    Open Access•Guy M Goodwin, Scott T Aaronson et al.•ARTICLE•New England Journal of Medicine•2022

    BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…

  • Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials

    Zachary Herrmann, M Earleywine et al.•ARTICLE•Journal of Psychoactive Drugs•2022

    Subjective responses to psychoactive drugs have served as intriguing windows into consciousness as well as useful predictors. Subjective reactions to psychedelic molecules are particularly interesting given how they covary with subsequent improvements associated with psychedelic-assisted treatments. Although links between subjective reactions and decreases in treatment-resistant clinical depression, end-of-life anxiety, and maladaptive consumptio…

  • The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk: Performance in adult primary care patients

    Open Access•Karabi Nandy, A John Rush et al.•ARTICLE•Frontiers in Psychiatry•2023

    The CHRT-SR 9 is a brief self-report evaluating suicidality with excellent psychometric properties that is sensitive to change over time

  • Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints

    Open Access•Sharon C Sung, Sharon Sung et al.•ARTICLE•Frontiers in Psychiatry•2026

    This newly derived model demonstrated strong diagnostic accuracy in identifying panic-related anxiety among ED patients with cardiopulmonary complaints, suggesting its potential utility in clinical screening. Implementation of this model may facilitate timely diagnosis, reduce repeated ED visits, and improve patient outcomes

Psychology (16 works) · Medicine (15 works) · Psychiatry (15 works) · Clinical Psychology (9 works) · Anxiety (7 works) · Depression (economics) (7 works) · Mental Health Treatment and Access (7 works) · Clinical Psychology (6 works) · Developmental psychology (6 works) · Treatment of Major Depression (6 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae